Celerion Vaccine Development. Global Access. Local Expertise. Learn More

Expertise from Working with Innovator Biologic Drugs


Biosimilars

A successful biosimilar program requires an in-depth understanding of the structure and function of the originator product to establish a target profile that can be used to evaluate bioanalytical similartity. With over 25 years of biologics drug development experience, Celerion provides an extensive list of bioanalytical assays, immunogenicity assessments and pharmacodynamic biomarkers.
View Assays


Immunogenicity Screening

View Case Study


Assay Efficiency: Combined Biosimilar & Innovator Assay

Biosimilars


Bioanalytical Assay Development

View Article

Biosimilars


Challenges and Solution, Bioanalytical Assays

View Video

Biosimilars


Expert in Development

View Expertise

Biosimilars


Turn-key Assays Development

View Article

Biosimilars


Adalimumab

View Development

Biosimilars


Ranibizumab

View Development

Biosimilars


Teriparatide

View Development

Biosimilars


Biosimilar Assay List

View Overview